1. Nrf2/Keap1/ARE regulation by plant secondary metabolites: a new horizon in brain tumor management.
- Author
-
Dewanjee, Saikat, Bhattacharya, Hiranmoy, Bhattacharyya, Chiranjib, Chakraborty, Pratik, Fleishman, Joshua, Alexiou, Athanasios, Papadakis, Marios, and Jha, Saurabh Kumar
- Subjects
- *
METABOLITES , *PLANT metabolites , *DEFENSE mechanisms (Psychology) , *BRAIN tumors , *BRAIN cancer - Abstract
Brain cancer is regarded as one of the most life-threatening forms of cancer worldwide. Oxidative stress acts to derange normal brain homeostasis, thus is involved in carcinogenesis in brain. The Nrf2/Keap1/ARE pathway is an important signaling cascade responsible for the maintenance of redox homeostasis, and regulation of anti-inflammatory and anticancer activities by multiple downstream pathways. Interestingly, Nrf2 plays a somewhat, contradictory role in cancers, including brain cancer. Nrf2 has traditionally been regarded as a tumor suppressor since its cytoprotective functions are considered to be the principle cellular defense mechanism against exogenous and endogenous insults, such as xenobiotics and oxidative stress. However, hyperactivation of the Nrf2 pathway supports the survival of normal as well as malignant cells, protecting them against oxidative stress, and therapeutic agents. Plants possess a pool of secondary metabolites with potential chemotherapeutic/chemopreventive actions. Modulation of Nrf2/ARE and downstream activities in a Keap1-dependant manner, with the aid of plant-derived secondary metabolites exhibits promise in the management of brain tumors. Current article highlights the effects of Nrf2/Keap1/ARE cascade on brain tumors, and the potential role of secondary metabolites regarding the management of the same. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF